The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.
Category: Vaccination and Immunization
-
F.D.A. Official Overruled Scientists on Wide Access to Covid Shots
The agency’s staff scientists pointed out how Covid was still unpredictable and posed a threat to toddlers, but the official decided to restrict shots only to children with risk factors.
-
CVS Holds Off on Offering Covid Vaccines in 16 States
The country’s largest pharmacy chain said it needed a C.D.C. panel to recommend the shots before it could offer them nationwide.
-
CDC Standoff: RFK Jr.’s Push to Fire Director Devolves Into Chaos
Lawyers for the agency’s chief, Susan Monarez, insist that the impasse with Health Secretary Robert F. Kennedy Jr. can only be resolved by President Trump.
-
F.D.A. Approves Covid Shots With New Restrictions
The agency’s fall recommendations underscore the goals of Health Secretary Robert F. Kennedy Jr. to limit access to the vaccines, which he has long opposed.
-
Covid Vaccine Opponent Tapped to Lead Federal Review Team
Panel members have been given a broad mandate, despite pleas from C.D.C. employees asking Robert F. Kennedy Jr. to stop spreading misinformation.
-
Top F.D.A. Official Overrode Scientists on Covid Shots
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
-
What to Know About Measles When Traveling
Summer travel raises fears that the highly infectious virus will spread. Here’s how to protect yourself and your family.
-
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
-
What to Put in a Travel First-Aid Kit: Key Items to Include
Experts weigh in on what to bring for a healthy, stress-free trip.
-
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.